Daily Bulletin

Men's Weekly

.

New data independently confirms and extends laboratory findings and expands safety profile of ATH434-PR Newswire APAC

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Cision

MELBOURNE, Australia and SAN FRANCISCO, Aug. 4, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced that new clinical and experimental pharmacology data for its lead drug candidate ATH434 (formerly PBT434) has been selected for presentation at the 2020 International Congress of...

Read more: New data independently confirms and extends laboratory findings and expands safety profile of...

More Articles ...

  1. Tile™ and Skullcandy Create Most Advanced True Wireless Finding Experience-PR Newswire APAC
  2. Trade360 Announces New Trading Platform-PR Newswire APAC
  3. Alterity Releases Appendix 4C - Q4 FY20 Quarterly Cash Flow Report-PR Newswire APAC

Business News

Reliable Materials Handling Solutions for Safer and Faster Workflows

Handling materials the wrong way can slow down operations and hurt workers. According to Safe Work Australia, manual tasks like lifting, carrying, and pushing are behind over 20% of serious workplac...

Daily Bulletin - avatar Daily Bulletin

Improving Leadership Skills Through Business Coaching

Good leadership has nothing to do with knowing everything. It's about being open to learning, making intelligent choices, and getting the best out of those around you. No matter if you work with a ...

Daily Bulletin - avatar Daily Bulletin

How to Choose the Right Business Networking Event in Brisbane for You

In Brisbane, there’s no shortage of business networking events that can help you grow your business, connect with key professionals, and discover new opportunities.  But with so many options, how d...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals